This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The first volunteers who received low or medium doses of Moderna's vaccine produced...
Genfit warns costs of failed NASH trial will drag deep into 2020 ntaylor Tue, 05/19/2020...
A group of major CRO, life science, data analytics, publishing and healthcare companies...
Credit: David Hocking What price are you willing to pay for food? As humans, we...
One of the more surprising elements of the pandemic is how well biotech IPOs have...
Scipio bioscience has raised €6M in a Series A round to launch cost-effective single-cell...
Researchers in Germany and France have combined synthetic biology with microfluidics...
Scientists demonstrated how the conversion of a plant derivative into fuels and...